Business Context and Reporting Period
Company: Inspire Medical Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 10, 2025
Reporting Period: Quarter and full year ended December 31, 2024
This filing serves as a notification that the Company issued a press release announcing its financial results for the period ended December 31, 2024. The full text of the press release is included as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text acts as a cover document and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1) and are not explicitly stated in the filing text provided.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. It only confirms the issuance of results for the quarter and full year ended December 31, 2024.
Guidance, Outlook, and Risks
- Investor Communications: The Company plans to participate in various meetings with investors and analysts in February and March 2025.
- Materials: Presentation materials for these meetings are furnished as Exhibit 99.2 and are available on the Company's Investor Relations website.
- Legal Disclaimer: Information in Items 2.02 and 7.01, including the press release and presentation materials, is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and Full Year 2024.
- Examine Exhibit 99.2 (Presentation Materials) for updated guidance, outlook, and strategic initiatives discussed in upcoming investor meetings.
- Verify the Company's status as an emerging growth company and any related accounting standard elections.
- Confirm the trading symbol (INSP) and exchange (New York Stock Exchange) for current market data.